<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?DTDIdentifier.IdentifierValue archivearticle.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName archivearticle.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id><journal-id journal-id-type="publisher-id">EID</journal-id><journal-title-group><journal-title>Emerging Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control and Prevention</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3944849</article-id><article-id pub-id-type="pmid">24564994</article-id><article-id pub-id-type="publisher-id">13-1353</article-id><article-id pub-id-type="doi">10.3201/eid2003.131353</article-id><article-categories><subj-group subj-group-type="heading"><subject>Dispatch</subject></subj-group><subj-group subj-group-type="article-type"><subject>Dispatch</subject></subj-group></article-categories><title-group><article-title>Crimean-Congo Hemorrhagic Fever among Health Care Workers, Turkey</article-title><alt-title alt-title-type="running-head">CCHF, Turkey</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Celikbas</surname><given-names>Aysel Kocagul</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dokuzo&#x0011f;uz</surname><given-names>Ba&#x0015f;ak</given-names></name></contrib><contrib contrib-type="author"><name><surname>Baykam</surname><given-names>Nurcam</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gok</surname><given-names>Sebnem Eren</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ero&#x0011f;lu</surname><given-names>Mustafa Necati</given-names></name></contrib><contrib contrib-type="author"><name><surname>Midilli</surname><given-names>Kenan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zeller</surname><given-names>Herve</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ergonul</surname><given-names>Onder</given-names></name></contrib><aff id="aff1">Ankara Numune Training and Research Hospital, Ankara, Turkey (A.K. Celikbas, B. Dokuzo&#x0011f;uz, N. Baykam, S.E. Gok, M.N. Ero&#x0011f;lu); </aff><aff id="aff2">Istanbul University, Istanbul, Turkey (K. Midilli); </aff><aff id="aff3">Institut Pasteur, Lyon, France (H. Zeller); </aff><aff id="aff4">Ko&#x000e7; University, Istanbul (O. Ergonul)</aff></contrib-group><author-notes><corresp id="cor1">Address for correspondence: Onder Ergonul, Ko&#x000e7; University, School of Medicine, Infectious Diseases Department, Istanbul, Turkey; email: <email xlink:href="oergonul@ku.edu.tr">oergonul@ku.edu.tr</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2014</year></pub-date><volume>20</volume><issue>3</issue><fpage>477</fpage><lpage>479</lpage><abstract><p>We investigated 9 cases of Crimean-Congo hemorrhagic fever (1 fatal, 2 asymptomatic) among health care workers in Turkey. Needlestick injuries were reported for 4 workers. Eight received ribavirin. In addition to standard precautions, airborne infection isolation precautions are essential during aerosol-generating procedures. For postexposure prophylaxis and therapy, ribavirin should be given.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>Crimean-Congo hemorrhagic fever</kwd><kwd>Turkey</kwd><kwd>viruses</kwd><kwd>health care workers</kwd><kwd>Bunyaviridae</kwd><kwd>vector-borne infections</kwd><kwd>zoonoses</kwd></kwd-group></article-meta></front><body><p>Crimean-Congo hemorrhagic fever (CCHF) has been described from Africa, Asia, southeastern Europe, and the Middle East (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). The CCHF virus (CCHFV) belongs to the family <italic>Bunyaviridae</italic>, genus <italic>Nairovirus</italic>, and causes severe disease in humans; the reported case-fatality rate is 3%&#x02013;30% (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). Humans become infected through the bites of ticks, contact with infected patients' body fluids, or contact with blood or tissues from viremic livestock. Health care workers (HCWs) are at occupational risk for CCHFV infection. Health care&#x02013;related CCHFV infections have been reported in Pakistan (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>&#x02013;<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>), the United Arab Emirates (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>), South Africa (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>), Iran (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>), India (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>), Tajikistan (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>), and Turkey (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref>). We describe the outcomes of 9 HCWs in Turkey who had occupational exposure to CCHFV.</p><sec><title>The Cases</title><p>The 9 HCWs and all CCHF patients under their care were admitted to the Infectious Diseases and Clinical Microbiology clinic (IDCM) of Ankara Numune Education and Research Hospital (Ankara, Turkey) during 2004&#x02013;2011 with confirmed CCHF. All 9 HCWs were aware of possible or confirmed CCHFV infection in their patients. During this period, &#x02248;7,000 confirmed CCHF cases were recorded in Turkey; nearly 300 of these patients were hospitalized in IDCM. Acute- and convalescent-phase serum samples from the index patients were sent to the national reference laboratory of Turkey. CCHFV infection was confirmed through IgM positivity by ELISA and/or positive PCR results for CCHFV in blood. After episode 1, the HCWs&#x02019; serum samples were sent to the Pasteur Institute (Lyon, France) for contact tracing. The HCWs&#x02019; infections were scored according to a severity score index (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>). In episode 3, to investigate the source of infection, molecular techniques were used. Oral ribavirin for treatment was administered at the dosage recommended by the World Health Organization (4 g/d for 4 d, 2.4 g/d for 6 d), and for prophylaxis (2g/4&#x000d7;/d for 7 d). The index patients and the HCWs were given erythrocyte, fresh frozen plasma, and total blood preparations depending on their homeostasis.</p><sec><title>Episode 1</title><p>In 2005, CCHFV infection was diagnosed in a woman on the day of delivery by cesarean section. She was transferred to IDCM, and her baby was transferred to the newborn service at the Dr. Sami Ulus Children's Hospital (Ankara, Turkey). A nurse in IDCM, who had fever and myalgia, was later found to have CCHFV infection (<xref ref-type="table" rid="T1">Table 1</xref>). Transmission was related to the improper use of gloves during the care of the mother&#x02019;s surgical wound. The mother recovered, but the infant died 5 days after birth. A nurse in the neonatal clinic in the children&#x02019;s hospital also acquired CCHFV infection, which was attributed to the intubation and aspiration of bloody secretions from the baby without proper use of gloves and mask. For both HCWs, the incubation period was 2 days. The first HCW was given ribavirin at symptom onset. The second nurse&#x02019;s illness was mild; because she had a potential for getting pregnant, ribavirin was not started. Both nurses recovered completely (<xref ref-type="table" rid="T2">Table 2</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><title>Clinical and laboratory findings of HCWs in whom Crimean-Congo hemorrhagic fever developed after occupational exposure, Turkey, 2004&#x02013;2011*&#x02020;</title></caption><table frame="hsides" rules="groups"><col width="61" span="1"/><col width="63" span="1"/><col width="63" span="1"/><col width="54" span="1"/><col width="43" span="1"/><col width="34" span="1"/><col width="34" span="1"/><col width="34" span="1"/><col width="48" span="1"/><col width="46" span="1"/><thead><tr><th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">HCW, outcome</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Body temperature, &#x000b0;C</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Bleeding</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Leukocytes/mm<sup>3</sup></th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Platelets/mm<sup>3</sup></th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">AST</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">ALT</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">APTT</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Fibrinogen</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">SSI</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1, survived</td><td valign="top" align="center" rowspan="1" colspan="1">38.5</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">800</td><td valign="top" align="center" rowspan="1" colspan="1">42,000</td><td valign="top" align="center" rowspan="1" colspan="1">425</td><td valign="top" align="center" rowspan="1" colspan="1">346</td><td valign="top" align="center" rowspan="1" colspan="1">44</td><td valign="top" align="center" rowspan="1" colspan="1">225</td><td valign="top" align="center" rowspan="1" colspan="1">Moderate</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">2, survived</td><td valign="top" align="center" rowspan="1" colspan="1">37.2</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1100</td><td valign="top" align="center" rowspan="1" colspan="1">53,000</td><td valign="top" align="center" rowspan="1" colspan="1">145</td><td valign="top" align="center" rowspan="1" colspan="1">81</td><td valign="top" align="center" rowspan="1" colspan="1">43</td><td valign="top" align="center" rowspan="1" colspan="1">270</td><td valign="top" align="center" rowspan="1" colspan="1">Mild</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">3, died</td><td valign="top" align="center" rowspan="1" colspan="1">40.5</td><td valign="top" align="center" rowspan="1" colspan="1">Ecchymosis, hematemesis, melena, hematuria</td><td valign="top" align="center" rowspan="1" colspan="1">11,100</td><td valign="top" align="center" rowspan="1" colspan="1">40,000</td><td valign="top" align="center" rowspan="1" colspan="1">251</td><td valign="top" align="center" rowspan="1" colspan="1">277</td><td valign="top" align="center" rowspan="1" colspan="1">90</td><td valign="top" align="center" rowspan="1" colspan="1">171</td><td valign="top" align="center" rowspan="1" colspan="1">Severe</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">4, survived</td><td valign="top" align="center" rowspan="1" colspan="1">40.5</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">2,900</td><td valign="top" align="center" rowspan="1" colspan="1">78,000</td><td valign="top" align="center" rowspan="1" colspan="1">150</td><td valign="top" align="center" rowspan="1" colspan="1">110</td><td valign="top" align="center" rowspan="1" colspan="1">37.4</td><td valign="top" align="center" rowspan="1" colspan="1">250</td><td valign="top" align="center" rowspan="1" colspan="1">Mild</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">5, survived</td><td valign="top" align="center" rowspan="1" colspan="1">39</td><td valign="top" align="center" rowspan="1" colspan="1">Epistaxis</td><td valign="top" align="center" rowspan="1" colspan="1">1,800</td><td valign="top" align="center" rowspan="1" colspan="1">58,000</td><td valign="top" align="center" rowspan="1" colspan="1">167</td><td valign="top" align="center" rowspan="1" colspan="1">129</td><td valign="top" align="center" rowspan="1" colspan="1">64</td><td valign="top" align="center" rowspan="1" colspan="1">218</td><td valign="top" align="center" rowspan="1" colspan="1">Moderate</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">6, survived</td><td valign="top" align="center" rowspan="1" colspan="1">40.5</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1,800</td><td valign="top" align="center" rowspan="1" colspan="1">44,000</td><td valign="top" align="center" rowspan="1" colspan="1">123</td><td valign="top" align="center" rowspan="1" colspan="1">216</td><td valign="top" align="center" rowspan="1" colspan="1">40.5</td><td valign="top" align="center" rowspan="1" colspan="1">165</td><td valign="top" align="center" rowspan="1" colspan="1">Moderate</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">7, survived</td><td valign="top" align="center" rowspan="1" colspan="1">39.1</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3,100</td><td valign="top" align="center" rowspan="1" colspan="1">13,000</td><td valign="top" align="center" rowspan="1" colspan="1">418</td><td valign="top" align="center" rowspan="1" colspan="1">132</td><td valign="top" align="center" rowspan="1" colspan="1">40.9</td><td valign="top" align="center" rowspan="1" colspan="1">170</td><td valign="top" align="center" rowspan="1" colspan="1">Moderate</td></tr></tbody></table><table-wrap-foot><p>*HCW, health care worker; AST, aspartate aminotransferase; ALT, alanine aminotransferase; APTT, activated partial thromboplastin time ; SSI, severity score index.&#x02028;&#x02020;Reference values: leukocytes, 4,000&#x02013;11,000/mm<sup>3</sup>; platelets, 150,000&#x02013;450,000/mm<sup>3</sup>; AST, &#x0003c;50 IU/L; ALT, &#x0003c;50 IU/L; APTT, 24&#x02013;36 sec; fibrinogen, 200&#x02013;400 mg/dL.</p></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><title>Demographic features of HCWs with occupational exposure to Crimean-Conger hemorrhagic fever virus, Turkey, 2004&#x02013;2011*</title></caption><table frame="hsides" rules="groups"><col width="70" span="1"/><col width="68" span="1"/><col width="76" span="1"/><col width="79" span="1"/><col width="54" span="1"/><col width="102" span="1"/><col width="29" span="1"/><thead><tr><th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Episode, outcome&#x02020;</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">HCW age, y/sex/profession</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Procedure</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Transmission route</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Ribavirin for postexposure prophylaxis</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Ribavirin for therapy (no. d after symptom onset)</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Fatal</th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1">Episode 1; survived, her baby died<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36/M/nurse</td><td valign="top" align="center" rowspan="1" colspan="1">Wound care</td><td valign="top" align="center" rowspan="1" colspan="1">Contact with surgical wound&#x02028;without protective equipment</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">Yes (0)</td><td valign="top" align="center" rowspan="1" colspan="1">No</td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">31/F/nurse<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Intubation, aspiration<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Aerosol and droplet and contact without protective equipment<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Episode 2; died<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28/F/nurse<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Phlebotomy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Needlestick<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Yes (3)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Yes<hr/></td></tr><tr><td rowspan="3" valign="top" align="left" scope="row" colspan="1">Episode 3; died<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">41/M/physician</td><td valign="top" align="center" rowspan="1" colspan="1">Resuscitation</td><td valign="top" align="center" rowspan="1" colspan="1">Aerosol and droplet</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">Yes (0)</td><td valign="top" align="center" rowspan="1" colspan="1">No</td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">26/M/physician</td><td valign="top" align="center" rowspan="1" colspan="1">Nasal tamponade</td><td valign="top" align="center" rowspan="1" colspan="1">Indirect contact</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">Yes (0)</td><td valign="top" align="center" rowspan="1" colspan="1">No</td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">29/M/physician<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Nasal tamponade<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Indirect contact<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Yes (0)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Episode 4; survived<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">30/M/nurse<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Phlebotomy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Needlestick<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Yes (1)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Episode 5; survived<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">30/F/nurse<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Phlebotomy<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Needlestick<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Yes<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">No<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Episode 6; survived</td><td valign="top" align="center" rowspan="1" colspan="1">24/F/physician</td><td valign="top" align="center" rowspan="1" colspan="1">Phlebotomy</td><td valign="top" align="center" rowspan="1" colspan="1">Needlestick</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">No</td></tr></tbody></table><table-wrap-foot><p>*HCW, health care worker; &#x02013;, ribavirin not necessary.&#x02028;&#x02020;Outcome for the index case-patient in each episode.</p></table-wrap-foot></table-wrap><p>After this episode, the index patient&#x02019;s contacts were traced. Serum samples from 37 HCWs at IDCM and the obstetrics and newborn clinics at the children&#x02019;s hospital who were at risk for infection were investigated for CCHF. In addition to the 2 nurses, 2 nurses from the neonatal clinic were CCHF IgM positive but were asymptomatic.</p></sec><sec><title>Episode 2</title><p>In 2006, a nurse received a needlestick injury during a phlebotomy of a CCHFV-infected patient. She was using gloves but no gown, and the needle stuck to her forearm. The infected patient died. The nurse&#x02019;s symptoms began 2 days after the incident, and she was transferred to IDCM 4 days after the incident. At admission, her severity score index was high. She had ecchymosis, epistaxis, hematemesis, melena, vaginal bleeding, and somnolence (<xref ref-type="table" rid="T1">Table 1</xref>). She received oral ribavirin 5 days after the incident, which possibly had limited effect because her illness already had progressed to confusion and gastrointestinal bleeding. She died on the second day after hospital admission.</p></sec><sec><title>Episode 3</title><p>In 2008, a patient with CCHFV infection and a high viral load (10<sup>8</sup> copies/mL) was hospitalized with hemoptysis, hematemesis, melena, epistaxis, and intraalveolar bleeding. He died 3 days after admission. One infectious diseases resident and 2 otorhinolaryngology residents acquired CCHFV infection. All HCWs had worn personal protective equipment during the intervention. One otorhinolaryngology resident performed nasal tamponade. After the intervention, the other otorhinolaryngology resident handled and cleaned a head mirror without using gloves, although he was not in face-to-face contact with the patient. The infectious diseases resident resuscitated the patient without apparent direct contact with the patient&#x02019;s bloody secretions. For the 3 residents, fever, malaise, and myalgia developed 2&#x02013;5 days after exposure. Ribavirin was started at symptom onset. No contact was observed between the patient and the HCWs, but the RNA sequences from the patients and HCWs were identical by molecular techniques. All of the HCWs recovered.</p><p>The transmission of CCHFV could have resulted from indirect contact with contaminated devices, such as the head mirror; the improper removal of gowns, masks, gloves; inadequate hand hygiene; or failure to use N95 masks during aerosolizing procedures. During the procedures that could generate aerosols, HCWs should wear an N95 mask or FFP2 respirator (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>). The patients with higher viral load were reported to be more severe disease (<xref rid="R14" ref-type="bibr"><italic>14</italic></xref>).</p></sec><sec><title>Episode 4</title><p>In 2008, a phlebotomist working in a children&#x02019;s hospital had a needlestick injury during phlebotomy of a CCHFV-infected child. He was hospitalized 1 day after symptom onset, and ribavirin was started. His severity score index was moderate, and he recovered.</p></sec><sec><title>Episodes 5 and 6</title><p>A nurse in 2007 and a pediatric resident in 2008 incurred needlestick injuries during phlebotomy of a CCHFV-infected patient. Postexposure prophylaxis with ribavirin was started immediately after the injuries, and no infections developed.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Six of the 9 CCHF-infected HCWs reported here had histories of needlestick injuries or contact with contaminated blood without adequate barrier precautions. An integrated strategy for controlling accidental exposure to body fluids was developed to protect HCWs against CCHFV infection. All personnel, including cleaning staff in health care units on all shifts were informed and trained about the transmission risks, protection, and clinical symptoms of CCHF (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>). The standard, contact, and droplet precautions were usually sufficient to protect against CCHFV infection during the routine care of CCHF patients. In addition to the practices of previous years, the airborne infection isolation precautions during aerosol-generating procedures were performed. The number of HCWs caring for patients with severe CCHF was limited. After all of these measures were enforced, occupational CCHFV infection did not occur in IDCM.</p><p>Ribavirin is an effective treatment for CCHFV infection (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>) and beneficial for postexposure prophylaxis (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>,<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>). Therapy should be started as early as possible. In the 2 HCWs reported here who received ribavirin for postexposure prophylaxis, no symptoms developed; similar reports will be useful for increasing the power of this conclusion. We used a ribavirin dosage of 2g/day, but no consensus exists about the dosage for postexposure prophylaxis.</p></sec></body><back><fn-group><fn fn-type="citation"><p><italic>Suggested citation for this article:</italic> Celikbas AK, Dokuzo&#x0011f;uz B, Baykam N, Gok SE, Ero&#x0011f;lu MN, Midilli K, et al. Crimean-Congo hemorrhagic fever among health care workers, Turkey. Emerg Infect Dis [Internet]. 2014 Mar [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2003.131353">http://dx.doi.org/10.3201/eid2003.131353</ext-link></p></fn></fn-group><bio id="d35e674"><p>Dr Celikbas is an infectious disease and clinical microbiology specialist at the Ankara Numune Training and Education Hospital in Ankara, Turkey. Her primary research interests include emerging infections and brucellosis.</p></bio><ref-list><title>References</title><ref id="R1"><label>1. </label><mixed-citation publication-type="webpage"><string-name><surname>Ergonul</surname><given-names>O</given-names></string-name>. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol. <year>2012</year>;2:215&#x02013;20.<ext-link ext-link-type="uri" xlink:href="http://"/><?supplied-pmid 22482717?></mixed-citation></ref><ref id="R2"><label>2. </label><mixed-citation publication-type="journal"><string-name><surname>Athar</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Khalid</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Ahmad</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Bashir</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Baqai</surname>
<given-names>HZ</given-names></string-name>, <string-name><surname>Ahmad</surname>
<given-names>M</given-names></string-name>, <etal/>
<article-title>Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002: contact tracing and risk assessment.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2005</year>;<volume>72</volume>:<fpage>471</fpage>&#x02013;<lpage>3</lpage> .<?supplied-pmid 15827289?><pub-id pub-id-type="pmid">15827289</pub-id></mixed-citation></ref><ref id="R3"><label>3. </label><mixed-citation publication-type="journal"><string-name><surname>Altaf</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Luby</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ahmed</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Zaidi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Mirza</surname>
<given-names>S</given-names></string-name>, <etal/>
<article-title>Outbreak of Crimean-Congo haemorrhagic fever in Quetta, Pakistan: contact tracing and risk assessment.</article-title>
<source>Trop Med Int Health</source>. <year>1998</year>;<volume>3</volume>:<fpage>878</fpage>&#x02013;<lpage>82</lpage> . <pub-id pub-id-type="doi">10.1046/j.1365-3156.1998.00318.x</pub-id><?supplied-pmid 9855399?><pub-id pub-id-type="pmid">9855399</pub-id></mixed-citation></ref><ref id="R4"><label>4. </label><mixed-citation publication-type="journal"><string-name><surname>Fisher-Hoch</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>McCormick</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Swanepoel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Van Middlekoop</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Harvey</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kustner</surname>
<given-names>HG</given-names></string-name>. <article-title>Risk of human infections with Crimean-Congo hemorrhagic fever virus in a South African rural community.</article-title>
<source>Am J Trop Med Hyg</source>. <year>1992</year>;<volume>47</volume>:<fpage>337</fpage>&#x02013;<lpage>45</lpage> .<?supplied-pmid 1524147?><pub-id pub-id-type="pmid">1524147</pub-id></mixed-citation></ref><ref id="R5"><label>5. </label><mixed-citation publication-type="journal"><string-name><surname>Burney</surname>
<given-names>MI</given-names></string-name>, <string-name><surname>Ghafoor</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Saleen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Webb</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Casals</surname>
<given-names>J</given-names></string-name>. <article-title>Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever&#x02013;Congo virus in Pakistan, January 1976.</article-title>
<source>Am J Trop Med Hyg</source>. <year>1980</year>;<volume>29</volume>:<fpage>941</fpage>&#x02013;<lpage>7</lpage> .<?supplied-pmid 7435795?><pub-id pub-id-type="pmid">7435795</pub-id></mixed-citation></ref><ref id="R6"><label>6. </label><mixed-citation publication-type="journal"><string-name><surname>Suleiman</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Muscat-Baron</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Harries</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Satti</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Platt</surname>
<given-names>GS</given-names></string-name>, <string-name><surname>Bowen</surname>
<given-names>ET</given-names></string-name>, <etal/>
<article-title>Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital.</article-title>
<source>Lancet</source>. <year>1980</year>;<volume>2</volume>:<fpage>939</fpage>&#x02013;<lpage>41</lpage> . <pub-id pub-id-type="doi">10.1016/S0140-6736(80)92103-0</pub-id><?supplied-pmid 6107588?><pub-id pub-id-type="pmid">6107588</pub-id></mixed-citation></ref><ref id="R7"><label>7. </label><mixed-citation publication-type="journal"><string-name><surname>van de Wal</surname>
<given-names>BW</given-names></string-name>, <string-name><surname>Joubert</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>van Eeden</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>King</surname>
<given-names>JB</given-names></string-name>. <article-title>A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part IV. Preventive and prophylactic measures.</article-title>
<source>S Afr Med J</source>. <year>1985</year>;<volume>68</volume>:<fpage>729</fpage>&#x02013;<lpage>32</lpage> .<?supplied-pmid 2414853?><pub-id pub-id-type="pmid">2414853</pub-id></mixed-citation></ref><ref id="R8"><label>8. </label><mixed-citation publication-type="journal"><string-name><surname>Mardani</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rahnavardi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rajaeinejad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Naini</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Chinikar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pourmalek</surname>
<given-names>F</given-names></string-name>, <etal/>
<article-title>Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2007</year>;<volume>76</volume>:<fpage>443</fpage>&#x02013;<lpage>5</lpage> .<?supplied-pmid 17360865?><pub-id pub-id-type="pmid">17360865</pub-id></mixed-citation></ref><ref id="R9"><label>9. </label><mixed-citation publication-type="journal"><string-name><surname>Mishra</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Mehta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mourya</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Gandhi</surname>
<given-names>S</given-names></string-name>. <article-title>Crimean-Congo haemorrhagic fever in India.</article-title>
<source>Lancet</source>. <year>2011</year>;<volume>378</volume>:<fpage>372</fpage> . <pub-id pub-id-type="doi">10.1016/S0140-6736(11)60680-6</pub-id><?supplied-pmid 21784269?><pub-id pub-id-type="pmid">21784269</pub-id></mixed-citation></ref><ref id="R10"><label>10. </label><mixed-citation publication-type="journal"><string-name><surname>Tishkova</surname>
<given-names>FH</given-names></string-name>, <string-name><surname>Belobrova</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Valikhodzhaeva</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Atkinson</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hewson</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mullojonova</surname>
<given-names>M</given-names></string-name>. <article-title>Crimean-Congo hemorrhagic fever in Tajikistan.</article-title>
<source>Vector Borne Zoonotic Dis</source>. <year>2012</year>;<volume>12</volume>:<fpage>722</fpage>&#x02013;<lpage>6</lpage> . <pub-id pub-id-type="doi">10.1089/vbz.2011.0769</pub-id><?supplied-pmid 22217164?><pub-id pub-id-type="pmid">22217164</pub-id></mixed-citation></ref><ref id="R11"><label>11. </label><mixed-citation publication-type="journal"><string-name><surname>T&#x000fc;t&#x000fc;nc&#x000fc;</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Gurbuz</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ozturk</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kuscu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Sencan</surname>
<given-names>I</given-names></string-name>. <article-title>Crimean Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report.</article-title>
<source>Scand J Infect Dis</source>. <year>2009</year>;<volume>41</volume>:<fpage>378</fpage>&#x02013;<lpage>80</lpage> . <pub-id pub-id-type="doi">10.1080/00365540902882434</pub-id><?supplied-pmid 19343611?><pub-id pub-id-type="pmid">19343611</pub-id></mixed-citation></ref><ref id="R12"><label>12. </label><mixed-citation publication-type="journal"><string-name><surname>Dokuzoguz</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Celikbas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Eren</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Baykam</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Eroglu</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Ergonul</surname>
<given-names>O</given-names></string-name>. <article-title>Severity scoring index for Crimean Congo hemorrhagic fever virus infection and the impact of ribavirin and corticosteroids on fatality.</article-title>
<source>Clin Infect Dis</source>. <year>2013</year>;<volume>57</volume>:<fpage>1270</fpage>&#x02013;<lpage>4</lpage> . <pub-id pub-id-type="doi">10.1093/cid/cit527</pub-id><?supplied-pmid 23946218?><pub-id pub-id-type="pmid">23946218</pub-id></mixed-citation></ref><ref id="R13"><label>13. </label><mixed-citation publication-type="book"><string-name><surname>Tarantola</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ergonul</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Tattevin</surname>
<given-names>P</given-names></string-name>. Estimates and prevention of Crimean Congo hemorrhagic fever risks for health care workers. In: Ergonul O, Whitehouse CA, editors. Crimean-Congo hemorrhagic fever: a global perspective. Dordrecht (the Netherlands): Springer; <year>2007</year>. p. 281&#x02013;94.</mixed-citation></ref><ref id="R14"><label>14. </label><mixed-citation publication-type="journal"><string-name><surname>Duh</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Saksida</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Petrovec</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ahmeti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dedushaj</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Panning</surname>
<given-names>M</given-names></string-name>, <etal/>
<article-title>Viral load as predictor of Crimean-Congo hemorrhagic fever outcome.</article-title>
<source>Emerg Infect Dis</source>. <year>2007</year>;<volume>13</volume>:<fpage>1769</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.3201/eid1311.070222</pub-id><?supplied-pmid 18217568?><pub-id pub-id-type="pmid">18217568</pub-id></mixed-citation></ref><ref id="R15"><label>15. </label><mixed-citation publication-type="journal"><string-name><surname>Ergonul</surname>
<given-names>O</given-names></string-name>. <article-title>Treatment of Crimean-Congo hemorrhagic fever.</article-title>
<source>Antiviral Res</source>. <year>2008</year>;<volume>78</volume>:<fpage>125</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2007.11.002</pub-id><?supplied-pmid 18096251?><pub-id pub-id-type="pmid">18096251</pub-id></mixed-citation></ref></ref-list></back></article>